The currently recommended five-day course of molnupiravir, an antiviral treatment, may not be long enough to treat COVID-19, according to a new paper involving Professor Joseph Standing (UCL Great Ormond Street Institute of Child Health).
Read: MSN, More: Medical Xpress, UCL News
Close
